Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experience

Idiopathic pulmonary fibrosis (IPF) is a fibrotic interstitial lung disease associated with significant morbidity and mortality. Previously, IPF has been managed using immunosuppressive therapy; however, it has been shown that this is associated with increased mortality. In the last 5 years, two dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivera-Ortega, Pilar, Hayton, Conal, Blaikley, John, Leonard, Colm, Chaudhuri, Nazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156214/
https://www.ncbi.nlm.nih.gov/pubmed/30249169
http://dx.doi.org/10.1177/1753466618800618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156214/
https://www.ncbi.nlm.nih.gov/pubmed/30249169
http://dx.doi.org/10.1177/1753466618800618

Ejemplares similares